Vice President & General Manager, EU North
Quick Summary
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research…
Organizational build. Establish the EU North operating entity from inception, including recruitment of the core leadership team, legal and infrastructure set-up, and governance in coordination with International HQ Launch leadership — Nordics.
You are a builder. You are comfortable operating before the organization beneath you is fully formed, and you exercise good judgement about which decisions to make yourself, which to delegate, and which to escalate.
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.
BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries —with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.
At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets with bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.
To learn more about our story and company culture, visit us at https://bridgebio.com
Responsibilities
~1 min readThe Vice President & General Manager, EU North, reporting to the SVP, Head of International, leads BridgeBio’s commercial presence across the Nordic region, the United Kingdom, and Ireland. The role carries full P&L responsibility for the cluster and is accountable for building the organization, shaping the commercial construct, and securing the external relationships required to bring our innovative medicines to patients across these markets, in close coordination with BridgeBio International headquarters in Zurich.
Bringing the Nordics, the United Kingdom, and Ireland under a single leadership mandate is deliberate. The clinical, payer, and advocacy networks that drive rare disease access across these geographies are deeply interconnected — published evidence travels, centers of expertise cross-refer, and national HTA bodies observe one another's decisions. Insight, credibility, and relationships built in one market compound across the cluster.
The successful candidate will join at the inception phase of our EU North operations, shape the organization from the first hire forward, and define how BridgeBio shows up to patients, clinicians, payers, and policymakers in the cluster for years to come.
Responsibilities
~2 min read- →At least ten years in senior commercial leadership roles with P&L responsibility, including at least one direct launch cycle within the EU North cluster (Nordics and/or UK)
- →Commercial launch experience in rare disease, orphan drugs, or specialty medicines, with demonstrated ability to navigate complex HTA and reimbursement environments
- →Deep working knowledge of market access across multiple countries in the cluster — engagement with authorities such as TLV, Nye Metoder, Medicinrådet, Fimea, NICE, SMC, and the NCPE — and experience with managed-access and risk-sharing agreements
- →Demonstrated personal track record of building and sustaining senior KOL and patient advocacy relationships in a rare disease or specialty context
- →Demonstrated ability to build and lead and leading high-performance teams in a start-up, early-affiliate, or greenfield environment
- →Experience operating across functions and geographies within a matrixed international organization
- →Prior launch or commercialization experience in cardiology, endocrinology, or skeletal dysplasia indications
- →Demonstrated capacity to carry both a launch market and a pre-launch market concurrently, with sound judgement on where to invest ahead of revenue
- →Background combining a larger company launch pedigree with a demonstrated capacity to operate in a lean, entrepreneurial setting
- →Fluency in English required. Fluency in one or more additional cluster languages is an asset but not a requirement
- Market leading compensation
- Hybrid work model - we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community
- We provide career development through regular feedback, continuous education and professional development programs
- We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
What We Offer
~1 min readLocation & Eligibility
Listing Details
- First seen
- April 24, 2026
- Last seen
- May 6, 2026
Posting Health
- Days active
- 12
- Repost count
- 0
- Trust Level
- 43%
- Scored at
- May 6, 2026
Signal breakdown
Please let Bridgebio know you found this job on Jobera.
4 other jobs at Bridgebio
View all →Explore open roles at Bridgebio.
Similar Chief Executive Officer jobs
View all →Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.
